Last Posted: Apr 04, 2019
- Opportunistic testing of BRCA1, BRCA2 and mismatch repair genes improves the yield of phenotype driven hereditary cancer gene panels.
Feliubadaló Lídia et al. International journal of cancer 2019 Mar - Selected features of breast and peritoneal cancers diagnosed in BRCA1 carriers after risk-reducing salpingo-oophorectomy.
Menkiszak Janusz et al. Hereditary cancer in clinical practice 2019 1710 - Leveraging Implementation Science to Address Health Disparities in Genomic Medicine: Examples from the Field.
Roberts Megan C et al. Ethnicity & disease 2019 29(Suppl 1) 187-192 - A response to "Personalised medicine and population health: breast and ovarian cancer".
Antoniou Antonis et al. Human genetics 2019 Mar 138(3) 287-289 - Author response to "a response to 'personalised medicine and population health: breast and ovarian cancer'".
Narod Steven A et al. Human genetics 2019 Mar 138(3) 291-292 - Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
Franceschini Gianluca et al. Annali italiani di chirurgia 2019 901-2 - BRACAVENIR: an observational study of expectations and coping in young women with high hereditary risk of breast and ovarian cancer.
Kwiatkowski Fabrice et al. Hereditary cancer in clinical practice 2019 177 - Concerns and Expectations of Risk-Reducing Surgery in Women with Hereditary Breast and Ovarian Cancer Syndrome.
Modaffari Paola et al. Journal of clinical medicine 2019 Mar 8(3) - Exploring genetic counselors' perceptions of usefulness and intentions to use refined risk models in clinical care based on the Technology Acceptance Model (TAM).
Heinlen Christopher et al. Journal of genetic counseling 2019 Mar - Selected medical interventions in women with a deleterious BRCA mutation: a population-based study in British Columbia.
Hanley G E et al. Current oncology (Toronto, Ont.) 2019 Feb 26(1) e17-e23
.png)
No hay comentarios:
Publicar un comentario